Jeremy Grantham Haleon PLC Transaction History
Grantham, Mayo, Van Otterloo & Co. LLC
- $29.2 Billion
- Q2 2024
A detailed history of Jeremy Grantham (Grantham, Mayo, Van Otterloo & Co. LLC) transactions in Haleon PLC stock. As of the latest transaction made, Grantham, Mayo, Van Otterloo & Co. LLC holds 38,508 shares of HLN stock, worth $397,787. This represents 0.0% of its overall portfolio holdings.
Number of Shares
38,508
Previous 28,534
34.95%
Holding current value
$397,787
Previous $242,000
31.4%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding HLN
# of Institutions
624Shares Held
422MCall Options Held
165KPut Options Held
26.7K-
Dodge & Cox San Francisco, CA180MShares$1.86 Billion0.94% of portfolio
-
Clearbridge Investments, LLC New York, NY41.8MShares$431 Million0.29% of portfolio
-
Harding Loevner LP Bridgewater, NJ25.6MShares$265 Million1.2% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa14MShares$144 Million0.05% of portfolio
-
Aristotle Capital Management, LLC Los Angeles, CA9.05MShares$93.5 Million0.15% of portfolio
About Haleon plc
- Ticker HLN
- Exchange
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 4,617,290,240
- Market Cap $47.7B
- Description
- Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, mineral...